Mark L. Berch

Array ( [id] => 5242948 [patent_doc_number] => 20070021443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Purine and imidazopyridine derivatives for immunosuppression' [patent_app_type] => utility [patent_app_number] => 11/398357 [patent_app_country] => US [patent_app_date] => 2006-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35782 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021443.pdf [firstpage_image] =>[orig_patent_app_number] => 11398357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341646 [patent_doc_number] => 07501404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Substituted azetidinones' [patent_app_type] => utility [patent_app_number] => 11/398438 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 136 [patent_figures_cnt] => 136 [patent_no_of_words] => 39577 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501404.pdf [firstpage_image] =>[orig_patent_app_number] => 11398438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5052101 [patent_doc_number] => 20070032646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Novel taxanes and methods related to use and preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/387458 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14097 [patent_no_of_claims] => 126 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032646.pdf [firstpage_image] =>[orig_patent_app_number] => 11387458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5521983 [patent_doc_number] => 20090029964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Novel carbapenem compound' [patent_app_type] => utility [patent_app_number] => 11/886949 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19020 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029964.pdf [firstpage_image] =>[orig_patent_app_number] => 11886949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53636 [patent_doc_number] => 07772392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Therapeutic substituted β-lactams' [patent_app_type] => utility [patent_app_number] => 11/378925 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10577 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772392.pdf [firstpage_image] =>[orig_patent_app_number] => 11378925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676951 [patent_doc_number] => 20080214582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Purine Derivatives as Inhibitors of Receptor Tyrosine Kinase Activity' [patent_app_type] => utility [patent_app_number] => 11/910776 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18679 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214582.pdf [firstpage_image] =>[orig_patent_app_number] => 11910776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196154 [patent_doc_number] => 07635693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof' [patent_app_type] => utility [patent_app_number] => 11/374814 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 59 [patent_no_of_words] => 18422 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635693.pdf [firstpage_image] =>[orig_patent_app_number] => 11374814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753252 [patent_doc_number] => 20080161327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Substituted 9-Alkyladenines and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/886086 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6462 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161327.pdf [firstpage_image] =>[orig_patent_app_number] => 11886086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760768 [patent_doc_number] => 20060211713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Compounds having selective hydrolytic potentials' [patent_app_type] => utility [patent_app_number] => 11/370164 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9402 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211713.pdf [firstpage_image] =>[orig_patent_app_number] => 11370164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632586 [patent_doc_number] => 20060149056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Stable bioavailable crystalline form of cefdinir and a process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/365915 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12369 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20060149056.pdf [firstpage_image] =>[orig_patent_app_number] => 11365915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005587 [patent_doc_number] => 20070203159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Purine compounds' [patent_app_type] => utility [patent_app_number] => 11/362771 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34254 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203159.pdf [firstpage_image] =>[orig_patent_app_number] => 11362771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7597615 [patent_doc_number] => 07618962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Pyrazolyl substituted xanthines' [patent_app_type] => utility [patent_app_number] => 11/362393 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9527 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618962.pdf [firstpage_image] =>[orig_patent_app_number] => 11362393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688877 [patent_doc_number] => 20070105821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines' [patent_app_type] => utility [patent_app_number] => 11/362390 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11776 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105821.pdf [firstpage_image] =>[orig_patent_app_number] => 11362390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211014 [patent_doc_number] => 20070249598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Derivatives of 8-substituted xanthines' [patent_app_type] => utility [patent_app_number] => 11/362392 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13421 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249598.pdf [firstpage_image] =>[orig_patent_app_number] => 11362392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228910 [patent_doc_number] => 07601723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Pyridyl substituted xanthines' [patent_app_type] => utility [patent_app_number] => 11/362387 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9509 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601723.pdf [firstpage_image] =>[orig_patent_app_number] => 11362387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656573 [patent_doc_number] => 20060142309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => '8-Heteroaryl xanthine adenosine A2B receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/359661 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27019 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142309.pdf [firstpage_image] =>[orig_patent_app_number] => 11359661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5447215 [patent_doc_number] => 20090048441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Process for the Preparation of Ezetimibe' [patent_app_type] => utility [patent_app_number] => 11/922358 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2971 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048441.pdf [firstpage_image] =>[orig_patent_app_number] => 11922358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656578 [patent_doc_number] => 20060142314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Rho-kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/354978 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5051 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142314.pdf [firstpage_image] =>[orig_patent_app_number] => 11354978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656577 [patent_doc_number] => 20060142313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Rho-kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/354977 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16652 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142313.pdf [firstpage_image] =>[orig_patent_app_number] => 11354977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4516484 [patent_doc_number] => 07932381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Process for producing carbapenem derivative and intermediate crystal therefor' [patent_app_type] => utility [patent_app_number] => 11/884195 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6630 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932381.pdf [firstpage_image] =>[orig_patent_app_number] => 11884195 [rel_patent_id] =>[rel_patent_doc_number] =>)